It is a pharma private limited company based in Salem, Tamil Nadu, India, established in 2013.
2013 | Salem, Tamil Nadu, India | Struck OffUnicordis Pharma India Private Limited, a struck off private limited company, was established on 23 April 2013 in Salem, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51909TZ2013PTC019418. Registered under ROC Roc Coimbatore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.80 M.
It upholds a active non-compliant status. Its leadership includes Karuppusamy Mohankumar (Additional Director), Kuppuswamy Manivannan (Director). Past directors included Arjunan Manimarane. Its latest AGM occurred on 30 September 2016, with the balance sheet filed on 31 March 2016. It is based at 2/231/14 Alagapuram Pudur, Salem, Tamil Nadu, 636016.
U51909TZ2013PTC019418
019418
23 April 2013
₹1.00 M
₹0.80 M
Roc Coimbatore
Unlisted
Struck Off
Explore comprehensive insights into Unicordis Pharma India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Karuppusamy Mohankumar | Additional Director | 18 Nov 2017 | Current |
| Kuppuswamy Manivannan | Director | 23 Apr 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Aug 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Unicordis Pharma India Private Limited, for the financial year ended 2016, experienced Minor drop in revenue, with a 2.21% decrease. The company also saw a substantial fall in profitability, with a 1276.8% decrease in profit. The company's net worth observed a substantial decline by a decrease of 198.6%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2016, Unicordis Pharma India had a promoter holding of 87.50% and a public holding of 12.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Unicordis Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Unicordis Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unicordis Pharma India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Karuppusamy Mohankumar was appointed as a Additional Director was appointed as a Additional Director on 18 Nov 2017 & has been associated with this company since 8 years 13 days . was completed.
Progress on Unicordis Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2016 as per latest MCA records. was documented.
Unicordis Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Coimbatore. was recorded as a recent event.
The activity Kuppuswamy Manivannan was appointed as a Director was appointed as a Director on 23 Apr 2013 & has been associated with this company since 12 years 7 months . was completed.
The activity Unicordis Pharma India Private Limited was registered on 23 Apr 2013 with Roc Coimbatore & aged 12 years 7 months as per MCA records. was completed.
The CIN of Unicordis Pharma India Private Limited is U51909TZ2013PTC019418.
Unicordis Pharma India Private Limited is headquartered at 2/231/14 Alagapuram Pudur, Salem, Tamil Nadu, 636016.
Unicordis Pharma India Private Limited was incorporated on 23 April 2013.
The current directors of Unicordis Pharma India Private Limited are
The primary industry of Unicordis Pharma India Private Limited is Pharma.
Unicordis Pharma India Private Limited is unlisted.
The authorized capital of Unicordis Pharma India Private Limited is ₹1.00 M, and the paid-up capital is ₹0.80 M.
The compliance status of Unicordis Pharma India Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX